Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 941-944-1 | 3’-deamino-3’’, 4’-anhydro-[2’’(S)-methoxy-3’’(R)-oxy-4’’-morpholinyl]doxorubicin |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 3 | H311 |
GHS08 GHS05 GHS06 Dgr |
State/Form
|
1 | View details | ||||||
| Skin Corr. 1B | H314 | ||||||||||
| Acute Tox. 3 | H331 | ||||||||||
| Carc. 1B | H350 | ||||||||||
| NA | |||||||||||
Number of Aggregated Notifications: 1